收稿日期: 2024-10-31
修回日期: 2024-11-26
网络出版日期: 2025-01-14
基金资助
上海市加强公共卫生体系建设三年行动计划（2023—2025年）重点学科项目(GWVI-11.1-12)
Interpretation of criteria for Detection of Leishmania: Smear Microscopy Exanimation
Received date: 2024-10-31
Revised date: 2024-11-26
Online published: 2025-01-14
Supported by
Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai (2023-2025) Key Discipline Project(GWVI-11.1-12)
依据《卫生标准管理办法》《标准化工作导则》（GB/T 1.1—2020）体例，编制了《利什曼原虫检测 涂片镜检法》（WS/T 10018—2024）。该标准由8章组成，包括范围、规范性引用文件、术语和定义、仪器设备、试剂或材料、检测步骤、结果判定和废弃物处理；另附有4个资料性附录（3个检测方法、试剂配制）。该标准由国家疾病预防控制局发布（国疾控通〔2024〕1号）通告，将于2025年3月1日正式实施。该标准为疾病预防控制机构和各级医疗机构规范开展涂片镜检利什曼原虫提供了技术规范。本文结合我国目前内脏利什曼病的流行情况，对该标准的主要内容进行了解读，以促进该标准的宣传贯彻和实施。
危芙蓉 , 俞铖航 , 郑彬 , 高春花 . 《利什曼原虫检测 涂片镜检法》标准解读[J]. 中国寄生虫学与寄生虫病杂志, 2024 , 42(6) : 763 -766 . DOI: 10.12140/j.issn.1000-7423.2024.06.011
In accordance with the Management Measures for Health Criteria and GB/T 1.1-2020 Standardization Work Guidelines, Detection of Leishmania - Smear Microscopic Exanimation (WS/T 10018-2024) (referred to as the Criteria) was compiled. The Criteria consists of eight chapters, including “the range of application”, “normative references”, “terms and definitions”, “instruments and equipment”, “reagent or materials”, “detection steps”, “result determination”, and “waste disposal”, attached with four informative appendices (three detection methods, reagent preparation). The Criteria was issued by the National Disease Control and Prevention Administration (National Center for Disease Control Circular [2024] No. 1) and will be formally implemented at start on March 1, 2025. The Criteria provides technical guideline specifications for smear microscopy in detecting Leishmania in medical institutions and disease prevention and control institutions. Combined with the current endemic situation of kala-azar in China, this paper interprets the main content of the Criteria to promote the publicity and implementation.
Key words： Leishmaniasis; Leishmania; Smear microscopic exanimation; Criteria
| [1] | Akhoundi M, Downing T, Votypka J, et al. Leishmania infections: molecular targets and diagnosis[J]. Mol Aspects Med, 2017, 57: 1-29. |
| [2] | Chufal SS, Pant P, Chachra U, et al. Role of haematological changes in predicting occurrence of leishmaniasis- a study in kumaon region of uttarakhand[J]. J Clin Diagn Res, 2016, 10(5): EC39-EC43. |
| [3] | Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence[J]. PLoS One, 2012, 7(5): e35671. |
| [4] | Zijlstra EE. Visceral leishmaniasis: a forgotten epidemic[J]. Arch Dis Child, 2016, 101(6): 561-567. |
| [5] | Ready PD. Epidemiology of visceral leishmaniasis[J]. Clin Epidemiol, 2014, 6: 147-154. |
| [6] | World Health Organization. Control of the leishmaniases.Report of a meeting of the WHO expert committee on the control of leishmaniasis[R]. Geneva: WHO, 2010. |
| [7] | Wang JY, Cui G, Chen HT, et al. Current epidemiological profile and features of visceral leishmaniasis in people’s republic of China[J]. Parasit Vectors, 2012, 5: 31. |
| [8] | Wang JY, Gao CH, Yang YT, et al. An outbreak of the desert sub-type of zoonotic visceral leishmaniasis in Jiashi, Xinjiang Uygur Autonomous Region, People’s Republic of China[J]. Parasitol Int, 2010, 59(3): 331-337. |
| [9] | Zhou ZB, Li YY, Zhang Y, et al. Prevalence of visceral leishmaniasis in China in 2018[J]. Chin J Parasitol Parasit Dis, 2020, 38(2): 175-180, 187. (in Chinese) |
| (周正斌, 李元元, 张仪, 等. 2018年全国内脏利什曼病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 175-180, 187.) | |
| [10] | Zhou ZB, Li YY, Zhang Y, et al. Prevalence of visceral leishmaniasis in China in 2019[J]. Chin J Parasitol Parasit Dis, 2020, 38(5): 602-607. (in Chinese) |
| (周正斌, 李元元, 张仪, 等. 2019年我国内脏利什曼病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(5): 602-607.) | |
| [11] | Li YY, Zhou ZB, Yang LM, et al. Epidemiological characteristics of visceral leishmaniasis in China in 2022[J]. Chin J Parasitol Parasit Dis, 2023, 41(6): 669-676. (in Chinese) |
| (李元元, 周正斌, 杨丽敏, 等. 2022年全国内脏利什曼病疫情特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(6): 669-676.) | |
| [12] | Zhou ZB, Li YY, Li ZQ, et al. Prevalence of visceral leishmaniasis in China in 2023[J]. Chin J Parasitol Parasit Dis, 2024, 42(5): 559-565. (in Chinese) |
| (周正斌, 李元元, 李中秋, 等. 2023年我国内脏利什曼病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(5): 559-565.) | |
| [13] | Zhao YN, Wang L, Li XL. Analysis of 2 children with kala-azar misdiagnosed as hemophagocytic syndrome[J]. Clin Focus, 2023, 38(8): 722-725. (in Chinese) |
| (赵雅男, 王丽, 李晓雷. 儿童黑热病误诊为嗜血细胞综合征2例原因分析[J]. 临床荟萃, 2023, 38(8): 722-725. ) | |
| [14] | Jia XX, Deng CQ. A case of visceral leishmaniasis misdiagnosed as liver cirrhosis induced by hepatitis C[J]. Chin J Parasitol Parasit Dis, 2023, 41(6): 776-779. (in Chinese) |
| (贾晓霞, 邓春青. 误诊为丙型病毒性肝炎肝硬化的内脏利什曼病1例[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(6): 776-779.) | |
| [15] | Jia ZZ, Liu HY, Jiang Q, et al. A case of visceral leishmaniasis misdiagnosed as a hematological disorder[J]. Chin J Parasitol Parasit Dis, 2023, 41(2): 257-259. (in Chinese) |
| (贾枕枕, 刘洪英, 江琦, 等. 误诊为血液病的内脏利什曼病1例[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 257-259.) | |
| [16] | Fu ZJ, Ruan W, Zhu HB, et al. Analysis of 4 imported cases of kala-azar that were previously misdiagnosed[J]. J Pathog Biol, 2021, 16(5): 567-569. (in Chinese) |
| (傅正军, 阮卫, 朱海博, 等. 青田县4例输入性黑热病误诊分析[J]. 中国病原生物学杂志, 2021, 16(5): 567-569.) |
/
| 〈 |
|
〉 |